Lifeward (LFWD) Shareholder's Equity Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.73% |
| Dec 31, 2025 | -50.22% |
| Sep 30, 2025 | -44.74% |
| Jun 30, 2025 | -42.84% |
| Mar 31, 2025 | -39.94% |
| Dec 31, 2024 | -40.48% |
| Sep 30, 2024 | -28.57% |
| Jun 30, 2024 | -17.81% |
| Mar 31, 2024 | -16.20% |
| Dec 31, 2023 | 28.79% |
| Sep 30, 2023 | 45.56% |
| Jun 30, 2023 | 70.50% |
| Mar 31, 2023 | 69.33% |
| Dec 31, 2022 | 84.92% |
| Sep 30, 2022 | 74.96% |
| Jun 30, 2022 | 67.34% |
| Mar 31, 2022 | 246.09% |
| Dec 31, 2021 | 258.19% |
| Sep 30, 2021 | 170.59% |
| Jun 30, 2021 | 278.62% |
| Mar 31, 2021 | 263.53% |
| Dec 31, 2020 | 80.43% |
| Sep 30, 2020 | 132.26% |
| Jun 30, 2020 | 51.78% |
| Mar 31, 2020 | 57.60% |
| Dec 31, 2019 | 9.28% |
| Sep 30, 2019 | 44.26% |
| Jun 30, 2019 | 28.97% |
| Mar 31, 2019 | -49.46% |
| Dec 31, 2018 | -54.70% |
| Dec 31, 2017 | -56.11% |
| Dec 31, 2016 | 13.62% |